Cookies on this website

We use cookies to ensure that we give you the best experience on our website. If you click 'Accept all cookies' we'll assume that you are happy to receive all cookies and you won't see this message again. If you click 'Reject all non-essential cookies' only necessary cookies providing core functionality such as security, network management, and accessibility will be enabled. Click 'Find out more' for information on how to change your cookie settings.

Jane Armitage is Emeritus Professor of Clinical Trials and Epidemiology. She was also Director of Training and Career Development for Oxford Population Health.

She joined the Clinical Trial Service Unit and Epidemiological Studies Unit (CTSU) in 1990, having qualified in clinical medicine in 1979. Jane worked in a variety of specialties over several years with particular experience in respiratory medicine, geriatrics and diabetes.

Since joining CTSU she has coordinated and been chief investigator for a series of large-scale randomised clinical trials in cardiovascular disease including the 20,000 participant MRC/BHF Heart Protection Study, the 12,000 participant SEARCH and the 25,000 participant HPS2-THRIVE studies, which were trials of lipid modification in people with or at risk of vascular disease.

In addition she was Chief Investigator for the BHF-supported ASCEND trial of aspirin and fish oils involving 15,000 people with diabetes.

 

This seminar is open to members of the University.